Involvement of PI3K/HIF-1α/c-MYC/iNOS Pathway in the Anticancer Effect of Suaeda vermiculata in Rats
Open Access
- 16 October 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (10) , 1470
Abstract
Suaeda vermiculata Forssk. ex JF Gmel. (SV), a traditional known plant, has shown in vitro cytotoxic activity against HepG2 and HepG-2/ADR (doxorubicin-resistant cells) liver cell carcinoma cell lines, as well as hepatoprotection against paracetamol and carbon tetrachloride (CCl4)-induced liver injury. The current study evaluated the protective effect of SV, administered against N-diethylnitrosamine (NDEA)-induced HCC in rats. The possible modulatory effect of SV on the PI3K/HIF-1α/c-MYC/iNOS pathway was investigated. Sixty male adult albino rats (200 ± 10 g) were equally classified into five groups. Group I served as a control; Group 2 (SV control group) received SV (p.o., 200 mg/kg body weight); Group 3 (NDEA-administered rats) received freshly prepared NDEA solution (100 mg/L); and Groups 4 and 5 received simultaneously, for 16 weeks, NDEA + SV extract (100 and 200 mg/kg, orally). NDEA-treated rats displayed significant increases in serum levels of AFP, CEA, PI3K, malondialdehyde (MDA), epidermal growth factor receptor (EGFR), and vascular endothelial growth factor (VEGFR), with increased liver tissue protein expression of fibrinogen concomitant and significantly decreased concentrations of antioxidant parameters (catalase (CAT), superoxide dismutase (SOD), and reduced glutathione (GSH)) in comparison to normal rats. On the flip side, AFP, CEA, PI3K, MDA, EGFR, and VEGFR serum levels were significantly reduced in rats that received NDEA with SV, both at low (SV LD) and high (SV HD) doses, accompanied by significant improvements in antioxidant parameters compared to the NDEA-treated group. Conclusions: SV possesses a significant hepatoprotective effect against NDEA-induced HCC via inhibiting the PI3K/HIF-1α/c-MYC/iNOS pathway, suggesting that SV could be a promising hepatocellular carcinoma treatment.Keywords
Funding Information
- Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia (QU-IF-1-2-2)
This publication has 46 references indexed in Scilit:
- A preliminary study on serum liver function indices of Diethylnitrosamine induced hepatocarcinogenesis and chemoprotective potential of Eclipta alba in male Wistar ratsVeterinary World, 2014
- Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinomaHepatology, 2014
- Delayed Administration of a Single Dose of Lithium Promotes Recovery from AKIJournal of the American Society of Nephrology, 2014
- Oxidative stress as a crucial factor in liver diseasesWorld Journal of Gastroenterology, 2014
- VEGF is essential for the growth and migration of human hepatocellular carcinoma cellsMolecular Biology Reports, 2011
- Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overviewJournal of Translational Medicine, 2011
- Pivotal Role of mTOR Signaling in Hepatocellular CarcinomaGastroenterology, 2008
- Increased oxidative stress precedes the onset of high-fat diet–induced insulin resistance and obesityMetabolism, 2008
- Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis†Hepatology, 2005
- NO‐Mediated Chemoresistance in C6 Glioma CellsAnnals of the New York Academy of Sciences, 2002